The Innovation Connection - The 2014 Science|Business Summit

The 2014 Science|Business Summit brought together leaders from research, industry and policy to debate how to best unleash Europe’s technological potential.

The Summit also recognised excellence in innovation by celebrating the achievements of visionary entrepreneurs, top universities, and corporate champions featured in the 6th Academic Enterprise Awards (ACES).

Programme Meet the finalists

Photos from the event

The Innovation Awards
Global Innovation Award
Related reporting
Europe must embrace disruptive innovation to produce global tech giants
Incremental innovation won’t do, experts say. At stake is leadership in life sciences, transportation, infrastructure and communications technologies
EIT opens contest for new food and manufacturing clusters
Industry, universities and research institutes invited to submit proposals by the summer
Ten steps to success in tech transfer: the case of KU Leuven
A new Science|Business report analyses the principles and strategies that lie at the heart of one of the world’s most productive tech transfer offices, Leuven Research and Development
2015 ACES finalists announced
Four spin-outs from Norway, Sweden and France will go through to final awards competition in Barcelona on 20 November 2015
Licensing and patents are an untapped source of cash for young companies
Selling ‘knowledge assets’ can help fund growth and lend start-ups credibility with investors. As China educates a new generation of innovators about intellectual property, Europe needs to raise its game.
ACES winner dials up literacy rates in Africa
A low-cost text message programme to help young people improve their English language skills won the Science|Business inaugural Global Innovation Award earlier this month. Its founder, Elvis Austins, spells out how he got here and what comes next
ACES Life Sciences winner InSphero adds a new dimension to toxicity testing of drugs
InSphero’s breakthrough in generating 3D cell models of human organs at scale for use in toxicity screens attracted potential customers to invest in proving the technology. Now all the top ten pharma companies are users
>More News & Analysis

Summit partners